This includes patients who are enrolled in Medicare Part B, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DoD) programs or TriCare, and patients who are Medicare eligible and enrolled in an employer-sponsored group waiver health plan or government-subsidized prescription drug benefit program for retirees. Patients who are enrolled in a state- or federally funded prescription insurance program are not eligible for this offer. Insured by Commercial insurance with a valid prescription for FASENRA ® (benralizumab) subcutaneousĪre a resident of the United States or Puerto Rico ANDĪre not enrolled in a government-funded program Patients may be eligible for this offer with the following criteria: Minnesota, or Rhode Island are not eligible for injection administration or injection training assistance.Įligibility for the FASENRA Savings Program Patients who are residents of Massachusetts, Michigan, Syringe and $100 per injection training for the FASENRA Pen. The FASENRA Savings Program has a program maximum of $100 per injection administration for prefilled To 24 months from the date of initial prescription. If you enroll you will receive support for up *Enrollment is open through December 31, 2022. This program is only administered by approved Specialty Pharmacies. The prescriber will need to submit a new Prior Authorization for you to Requirements may provide the opportunity for you to transition from the Denied Patient Savings Program Have FASENRA prescribed for an approved useĪ change in your insurance coverage or the insurance company’s Prior Authorization Have had your Prior Authorization and Prior Authorization appeal denied by your insurance company If you are not approved to receive FASENRA by your health plan and an appeal has beenĭenied, the Denied Patient Savings Program may cover the cost of the product for up to 2 years* when you
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |